IGC Pharma (IGC) announced the expansion of its ongoing Phase 2 CALMA clinical trial with the addition of Butler Hospital’s Memory and Aging ...

The Department of Health - Abu Dhabi (DoH), has successfully completed a groundbreaking clinical trial in Abu Dhabi, in ...

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

A new kind of vaccine is changing how people think about preventing breast cancer. Not just any breast cancer—this one ...

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to clinical trials.

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

PRNewswire/ - NetraMark Holdings Inc. (the Company or NetraMark) (CSE: AIAI) (OTCQB: AINMF ) (Frankfurt: 8TV) </b ...

In a phase 2b study, treatment with a once-daily oral PCSK9 inhibitor added to statin therapy resulted in a more than 50% ...